Elevated IRS‐1 pS616 Pathology in Human Hippocampal Area CA1 as a Biomarker of Preclinical and Alzheimer's Disease Dementia

Xuelin Gu, Tim Distel, Konrad Talbot · 2025

Read Elevated IRS‐1 pS616 Pathology in Human Hippocampal Area CA1 as a Biomarker of Preclinical and Alzheimer's Disease Dementia by Xuelin Gu, Tim Distel, Konrad Talbot (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714677.txt.

Description

Xuelin Gu, Tim Distel, and Konrad Talbot hunt a brain marker of insulin resistance in Alzheimer's disease in a 2025 study. The brain's poor response to insulin is common in the disease, but no clear tissue marker for it existed.

One candidate is a signaling protein tagged at a specific site. In healthy brains the tag sits mostly in cell nuclei of a key memory region. In Alzheimer's brains it spreads into the cell body. The team stained tissue from 217 donors across five groups, from healthy to full dementia, and let a trained network count the marked cells. They ask whether the shift flags disease before symptoms, as a preclinical marker beside the standard amyloid and tau measures.

Catalog record

CREATORXuelin Gu, Tim Distel, Konrad Talbot
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11714677

Browse the full library · About the Tower of Babel